Coltene Holding AG (CLTN) - Net Assets
Based on the latest financial reports, Coltene Holding AG (CLTN) has net assets worth CHF90.43 Million CHF (≈ $114.33 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF177.22 Million ≈ $224.05 Million USD) and total liabilities (CHF86.79 Million ≈ $109.72 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Coltene Holding AG to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CHF90.43 Million |
| % of Total Assets | 51.03% |
| Annual Growth Rate | 0.78% |
| 5-Year Change | 20.57% |
| 10-Year Change | 7.11% |
| Growth Volatility | 37.74 |
Coltene Holding AG - Net Assets Trend (2004–2024)
This chart illustrates how Coltene Holding AG's net assets have evolved over time, based on quarterly financial data. Also explore CLTN total assets for the complete picture of this company's asset base.
Annual Net Assets for Coltene Holding AG (2004–2024)
The table below shows the annual net assets of Coltene Holding AG from 2004 to 2024. For live valuation and market cap data, see CLTN company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CHF108.80 Million ≈ $137.55 Million |
+12.31% |
| 2023-12-31 | CHF96.87 Million ≈ $122.47 Million |
-13.65% |
| 2022-12-31 | CHF112.18 Million ≈ $141.83 Million |
+4.46% |
| 2021-12-31 | CHF107.40 Million ≈ $135.78 Million |
+19.02% |
| 2020-12-31 | CHF90.23 Million ≈ $114.08 Million |
-1.07% |
| 2019-12-31 | CHF91.21 Million ≈ $115.31 Million |
-69.20% |
| 2018-12-31 | CHF296.17 Million ≈ $374.44 Million |
+143.35% |
| 2017-12-31 | CHF121.70 Million ≈ $153.87 Million |
+8.42% |
| 2016-12-31 | CHF112.25 Million ≈ $141.92 Million |
+10.51% |
| 2015-12-31 | CHF101.58 Million ≈ $128.42 Million |
-2.44% |
| 2014-12-31 | CHF104.12 Million ≈ $131.63 Million |
+6.62% |
| 2013-12-31 | CHF97.65 Million ≈ $123.46 Million |
+0.82% |
| 2012-12-31 | CHF96.86 Million ≈ $122.46 Million |
+2.40% |
| 2011-12-31 | CHF94.59 Million ≈ $119.59 Million |
-3.33% |
| 2010-12-31 | CHF97.85 Million ≈ $123.71 Million |
-11.63% |
| 2009-12-31 | CHF110.73 Million ≈ $139.99 Million |
-2.15% |
| 2008-12-31 | CHF113.16 Million ≈ $143.07 Million |
-31.69% |
| 2007-12-31 | CHF165.66 Million ≈ $209.45 Million |
+11.04% |
| 2006-12-31 | CHF149.20 Million ≈ $188.62 Million |
+13.56% |
| 2005-12-31 | CHF131.38 Million ≈ $166.10 Million |
+41.05% |
| 2004-12-31 | CHF93.15 Million ≈ $117.77 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Coltene Holding AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 151.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CHF256.95 Million | 236.18% |
| Common Stock | CHF598.00K | 0.55% |
| Other Comprehensive Income | CHF77.14 Million | 70.90% |
| Total Equity | CHF108.80 Million | 100.00% |
Coltene Holding AG Competitors by Market Cap
The table below lists competitors of Coltene Holding AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Crescent Biopharma, Inc.
NASDAQ:CBIO
|
$292.50 Million |
|
Zhihu Inc ADR
NYSE:ZH
|
$292.52 Million |
|
FSP Technology Inc
TW:3015
|
$292.63 Million |
|
Amarin Corporation PLC
NASDAQ:AMRN
|
$292.71 Million |
|
Elma Electronic AG
SW:ELMN
|
$292.47 Million |
|
Taiwan Fire & Marine Insurance Co Ltd
TW:2832
|
$292.44 Million |
|
Fortress Value Acquisition Corp. V Class A Ordinary Shares
NASDAQ:FVAV
|
$292.39 Million |
|
Colony Bankcorp Inc.
NASDAQ:CBAN
|
$292.30 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Coltene Holding AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 96,874,000 to 108,796,000, a change of 11,922,000 (12.3%).
- Net income of 20,466,000 contributed positively to equity growth.
- Dividend payments of 11,946,000 reduced retained earnings.
- Share repurchases of 123,000 reduced equity.
- Other comprehensive income decreased equity by 8,527,000.
- Other factors increased equity by 12,052,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CHF20.47 Million | +18.81% |
| Dividends Paid | CHF11.95 Million | -10.98% |
| Share Repurchases | CHF123.00K | -0.11% |
| Other Comprehensive Income | CHF-8.53 Million | -7.84% |
| Other Changes | CHF12.05 Million | +11.08% |
| Total Change | CHF- | 12.31% |
Book Value vs Market Value Analysis
This analysis compares Coltene Holding AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.56x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 2.36x to 2.56x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | CHF19.77 | CHF46.60 | x |
| 2005-12-31 | CHF28.07 | CHF46.60 | x |
| 2006-12-31 | CHF32.15 | CHF46.60 | x |
| 2007-12-31 | CHF35.74 | CHF46.60 | x |
| 2008-12-31 | CHF24.84 | CHF46.60 | x |
| 2009-12-31 | CHF26.69 | CHF46.60 | x |
| 2010-12-31 | CHF23.58 | CHF46.60 | x |
| 2011-12-31 | CHF22.81 | CHF46.60 | x |
| 2012-12-31 | CHF23.12 | CHF46.60 | x |
| 2013-12-31 | CHF23.16 | CHF46.60 | x |
| 2014-12-31 | CHF24.68 | CHF46.60 | x |
| 2015-12-31 | CHF24.09 | CHF46.60 | x |
| 2016-12-31 | CHF26.63 | CHF46.60 | x |
| 2017-12-31 | CHF28.86 | CHF46.60 | x |
| 2018-12-31 | CHF62.83 | CHF46.60 | x |
| 2019-12-31 | CHF15.27 | CHF46.60 | x |
| 2020-12-31 | CHF15.10 | CHF46.60 | x |
| 2021-12-31 | CHF17.97 | CHF46.60 | x |
| 2022-12-31 | CHF18.78 | CHF46.60 | x |
| 2023-12-31 | CHF16.21 | CHF46.60 | x |
| 2024-12-31 | CHF18.21 | CHF46.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Coltene Holding AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 18.81%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.18%
- • Asset Turnover: 1.34x
- • Equity Multiplier: 1.72x
- Recent ROE (18.81%) is above the historical average (15.94%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 14.29% | 6.08% | 0.88x | 2.67x | CHF4.00 Million |
| 2005 | 13.79% | 7.34% | 0.97x | 1.93x | CHF4.99 Million |
| 2006 | 15.17% | 9.06% | 1.01x | 1.66x | CHF7.72 Million |
| 2007 | 15.87% | 9.59% | 1.11x | 1.49x | CHF9.73 Million |
| 2008 | 42.48% | 28.88% | 1.03x | 1.43x | CHF36.75 Million |
| 2009 | 14.77% | 10.80% | 0.96x | 1.42x | CHF5.28 Million |
| 2010 | 9.49% | 6.05% | 0.97x | 1.62x | CHF-499.80K |
| 2011 | 6.33% | 4.10% | 0.97x | 1.58x | CHF-3.47 Million |
| 2012 | 9.84% | 6.03% | 1.03x | 1.58x | CHF-156.00K |
| 2013 | 13.51% | 8.24% | 1.09x | 1.50x | CHF3.42 Million |
| 2014 | 15.01% | 9.63% | 0.99x | 1.58x | CHF5.22 Million |
| 2015 | 13.13% | 8.63% | 1.04x | 1.47x | CHF3.18 Million |
| 2016 | 15.38% | 10.75% | 1.00x | 1.43x | CHF6.04 Million |
| 2017 | 15.66% | 11.35% | 1.00x | 1.37x | CHF6.89 Million |
| 2018 | 5.03% | 7.31% | 0.49x | 1.42x | CHF-14.71 Million |
| 2019 | 21.96% | 7.32% | 1.44x | 2.08x | CHF10.91 Million |
| 2020 | 9.12% | 3.31% | 1.32x | 2.08x | CHF-791.40K |
| 2021 | 29.52% | 11.36% | 1.50x | 1.74x | CHF20.97 Million |
| 2022 | 23.18% | 9.73% | 1.40x | 1.70x | CHF14.78 Million |
| 2023 | 12.33% | 4.92% | 1.38x | 1.81x | CHF2.26 Million |
| 2024 | 18.81% | 8.18% | 1.34x | 1.72x | CHF9.59 Million |
Industry Comparison
This section compares Coltene Holding AG's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $3,807,533,298
- Average return on equity (ROE) among peers: 11.65%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Coltene Holding AG (CLTN) | CHF90.43 Million | 14.29% | 0.96x | $292.50 Million |
| Alcon AG (ALC) | $21.55 Billion | 4.72% | 0.41x | $30.03 Billion |
| SKAN Group AG (SKAN) | $86.87 Million | 5.15% | 0.02x | $1.13 Billion |
| Straumann Holding AG (STMN) | $623.50 Million | 28.21% | 0.52x | $15.48 Billion |
| Tecan Group AG (TECN) | $143.33 Million | 9.74% | 1.36x | $1.72 Billion |
| IVF Hartmann Holding AG (VBSN) | $48.48 Million | 21.37% | 0.47x | $336.00 Million |
| Ypsomed Holding AG (YPSN) | $390.03 Million | 0.70% | 0.60x | $3.85 Billion |
About Coltene Holding AG
COLTENE Holding AG develops, manufactures, and sells disposables, tools, and equipment for dentists and dental laboratories in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. The company offers restoration products, including conventional composites, bulk-fill composites, CAD/CAM solutions, core build-ups, bondings, etching gels, temporary materials, luting, curin… Read more